|
|
|
Volumn 36, Issue 4, 2011, Pages 178-
|
|
President obama reopens debate on patented biologics: Will the FDA quickly define an abbreviated pathway for biosimilars?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BUDGET;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
NOTE;
ORGANIZATION;
PATENT;
PUBLIC FIGURE;
|
|
EID: 79955715106
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
